COMMUNIQUÉS West-GlobeNewswire

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
BRISBANE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 1, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
BOSTON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on September 1, 2026, the Compensation [...]
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
04/09/2026
LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Wells Fargo 21 st Annual Healthcare [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
MIAMI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
CAMBRIDGE, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization [...]
Spyre Therapeutics Announces Grants of Inducement Awards
04/09/2026
WALTHAM, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/09/2026
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2026, the [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
WESTLAKE VILLAGE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]
TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
04/09/2026
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team [...]
Orion Corporation: Acquisition of own shares during week 36, 2026
04/09/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 4 September 2026 at 19.00 EEST Orion Corporation: Acquisition of own shares during week 36, 2026 The share buybacks form part of the share [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
04/09/2026
COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) has received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]
Declaration of shares and voting rights - Status as of August 31, 2026
04/09/2026
VALNEVA Declaration of shares and voting rights Status as of August 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint [...]
Déclaration d’actions et de droits de vote - Statut au 31 août 2026
04/09/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 31 août 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social [...]
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
04/09/2026
RAANANA, ISRAEL, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced [...]
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
04/09/2026
TEL AVIV, Israel, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that S&P Global Ratings ("S&P") has upgraded Teva’s long-term issuer credit rating [...]
Betterbrand Emphasizes Third-Party Testing as Consumers Demand Supplement Transparency
04/09/2026
Independent testing and ingredient verification remain central to Betterbrand's quality standards San Antonio, TX, Sept. 04, 2026 (GLOBE NEWSWIRE) -- SAN ANTONIO, TX — June 27, 2026 — As consumer scrutiny of dietary [...]
BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows
04/09/2026
New capability lets operational teams connect existing cameras, sensors and physical systems into site-specific response logic - and change it on screen without code, software releases or developer support NETANYA, [...]
Merit Medical to Participate in Upcoming Investors Conferences in September
04/09/2026
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following [...]
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference
04/09/2026
PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and [...]

Pages